BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

SILVERBACK ASSET MANAGEMENT LLC's Holding History (CIK: 0001278960)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 26,950,000 Value ($000) $30,352 Avg Close — Range —
Q3 2025
Shares 9,450,000 Value ($000) $9,350 Avg Close — Range —
Q2 2025
Shares 13,000,000 Value ($000) $12,172 Avg Close — Range —
Q1 2025
Shares 9,000,000 Value ($000) $8,100 Avg Close — Range —
Q4 2024
Shares 10,000,000 Value ($000) $8,544 Avg Close — Range —
Q3 2024
Shares 7,000,000 Value ($000) $5,854 Avg Close — Range —
Q2 2024
Shares 10,000,000 Value ($000) $8,076 Avg Close — Range —
Q1 2024
Shares 4,500,000 Value ($000) $3,707 Avg Close — Range —
Q4 2023
Shares 5,000,000 Value ($000) $4,215 Avg Close — Range —
Q3 2023
Shares 5,000,000 Value ($000) $3,750 Avg Close — Range —